Literature DB >> 10480437

Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.

M Galotto1, G Berisso, L Delfino, M Podesta, L Ottaggio, S Dallorso, C Dufour, G B Ferrara, A Abbondandolo, G Dini, A Bacigalupo, R Cancedda, R Quarto.   

Abstract

Bone marrow transplant (BMT) relies on the engraftment of donor hemopoietic precursors in the host marrow space. Colony forming units-fibroblasts (CFU-f), the precursor compartment for the osteogenic lineage, are essential to hemopoietic stem cell survival, proliferation and differentiation. We have studied CFU-f in donors (aged 5 months to 62 years) and in patients who had received allogeneic BMT (aged 2 months to 63 years). In donor marrows we found an inverse correlation between CFU-f frequency and age. In BMT recipients CFU-f frequencies were reduced by 60%-90% (p < 0.05) and the numbers did not recover up to 12 years after transplant. Stromal reconstitution to normal levels was found only in patients < 5 years old. In all patients studied CFU-f post-BMT were of host origin. Patients with low CFU-f levels displayed also a decreased bone mineral density (p < 0.05) and significantly reduced levels of long-term culture-initiating cells (LTC-IC) (p < 0.05). Our study demonstrates that the marrow stromal microenvironment is seriously and irreversibly damaged after BMT. Donor cells do not contribute to reconstitute the marrow microenvironment, whose residual CFU-fs remain of host origin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480437     DOI: 10.1016/s0301-472x(99)00076-4

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  59 in total

Review 1.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 2.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

3.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

Authors:  Christopher C Dvorak; Clarisa R Gracia; Jean E Sanders; Edward Y Cheng; K Scott Baker; Michael A Pulsipher; Anna Petryk
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-17       Impact factor: 5.742

Review 4.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

5.  Effect of mesenchymal stem cell transplantation on the engraftment of human hematopoietic stem cells and leukemic cells in mice model.

Authors:  Seung-Tae Lee; Hoyoung Maeng; Yong-Joon Chwae; Duk Jae Oh; Yong-Man Kim; Woo Ick Yang
Journal:  Int J Hematol       Date:  2008-02-22       Impact factor: 2.490

Review 6.  Application of stem cells in bone repair.

Authors:  Elaine Y L Waese; Rita A Kandel; Rita R Kandel; William L Stanford
Journal:  Skeletal Radiol       Date:  2008-01-12       Impact factor: 2.199

7.  Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain.

Authors:  A Dumas; M Brigitte; M F Moreau; F Chrétien; M F Baslé; D Chappard
Journal:  Osteoporos Int       Date:  2008-06-12       Impact factor: 4.507

Review 8.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

9.  Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

Authors:  M A Gertz; S K Kumar; M Q Lacy; A Dispenzieri; S R Hayman; F K Buadi; D Dingli; D A Gastineau; J L Winters; M R Litzow
Journal:  Bone Marrow Transplant       Date:  2008-11-10       Impact factor: 5.483

10.  Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia.

Authors:  Keisuke Shirai; Yasuhiko Sera; William Bulkeley; Meenal Mehrotra; Omar Moussa; Amanda C LaRue; Dennis K Watson; Robert K Stuart; John Lazarchick; Makio Ogawa
Journal:  Exp Hematol       Date:  2009-09-26       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.